Reducing Pharmaceutical Waste Through Enzyme Driven Catalysis
Pharmaceutical manufacturers are under increasing pressure to improve production efficiency while reducing their environmental impact. As regulations become stricter and sustainability takes centre stage, reducing pharmaceutical waste has become a key priority. Traditional manufacturing processes often generate large volumes of chemical waste, solvents, and unwanted by products, making production both expensive and resource intensive. Enzymatic catalysis is helping address this challenge by making pharmaceutical synthesis cleaner, more efficient, and significantly less wasteful. Much of the waste generated during pharmaceutical manufacturing originates during chemical synthesis. Conventional processes frequently involve multiple reaction stages, harsh chemicals, and metal based catalysts that produce unwanted side products. These impurities require additional purification, increasing solvent consumption, wastewater generation, and processing time. Instead of treating waste after it is ...